Citation Impact
Citing Papers
Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline
2020 Standout
Oxidative Stress
2017 Standout
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
2011 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Prevalence and associated factors of sarcopenia in older adults with intellectual disabilities
2012
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Breast cancer
2019 Standout
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
2013
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
2013
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Cancer to bone: a fatal attraction
2011 Standout
Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression
2007
Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)
2014 Standout
Metabolic syndrome meets osteoarthritis
2012
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Management of NAFLD: a stage-based approach
2016
Hallmarks of aging: An expanding universe
2023 Standout
OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis
2006
Genetic determinants of the metabolic syndrome
2006
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway
2013
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
2015
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic Syndrome
2007
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications
2006
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
2014
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016
Non-alcoholic fatty liver disease
2021 Standout
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population
2014
Relation of Physical Activity to Prevalence of Nonalcoholic Fatty Liver Disease Independent of Cardiometabolic Risk
2014
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Osteoporosis, inflammation and ageing
2005
Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
2016
Real-Time Noninvasive Imaging of Fatty Acid Uptake in Vivo
2012 StandoutNobel
Sarcopenia
2019 Standout
NAD+ homeostasis in health and disease
2020
Therapeutic Landscape for NAFLD in 2020
2020
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults
2017
Gastric cancer
2020 Standout
Periodontitis: a polymicrobial disruption of host homeostasis
2010 Standout
CD39 and CD73 in immunity and inflammation
2013 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
What We Talk About When We Talk About Fat
2014 Standout
Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-year prospective cohort study
2012
Down‐regulation of epidermal growth factor receptor‐dependent signaling by Porphyromonas gingivalis lipopolysaccharide in life‐expanded human gingival fibroblasts
2008
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Osteoporosis after solid organ and bone marrow transplantation
2003
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Regulation of Bone Mineral Density in Morbidly Obese Women: A Cross-sectional Study in Two Cohorts Before and After Bypass Surgery
2008
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients
2007
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
2013
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
2014
Transplantation of adipose tissue and stem cells: role in metabolism and disease
2010
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
2014
NAFLD: A multisystem disease
2015 Standout
Biomarkers in Heart Failure
2008 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
PPARγ in human and mouse physiology
2007
Soy Isoflavone Genistein Is a Potential Agent for Metabolic Syndrome Treatment: A Narrative Review
2020
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea
2013
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
2014
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Prevalence of nonalcoholic fatty liver disease in mainland of C hina: A meta‐analysis of published studies
2013
De novolipogenesis in the liver in health and disease: more than just a shunting yard for glucose
2015
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Diabetic Kidney Disease
2017 Standout
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Genetics in Arterial Calcification
2011
Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes
2015
Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study
2014
Skeletal Complications of Breast Cancer Therapies
2006
Plasma Osteoprotegerin Levels in the General Population
2007
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men
2015
Non‐alcoholic fatty liver disease in diabetics – prevalence and predictive factors in a multiracial hospital clinic population in M alaysia
2013
The Metabolic Syndrome
2008 Standout
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
2015
Contribution of Statins towards Periodontal Treatment: A Review
2019
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
2022
Nonalcoholic Fatty Liver Disease
2015 Standout
Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population
2016
Peri‐implantitis
2018 Standout
Works of Ki Won Oh being referenced
Association of osteoporosis susceptibility genes with bone mineral density and bone metabolism related markers in Koreans: The Chungju Metabolic Disease Cohort (CMC) study
2014
Impact of Nonalcoholic Fatty Liver Disease on Insulin Resistance in Relation to HbA1c Levels in Nondiabetic Subjects
2010
Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes
2013
Relationship between circulating cytokine levels and thyroid function following bone marrow transplantation
2004
Relationship between Subclinical Thyroid Dysfunction and Femoral Neck Bone Mineral Density in Women
2006
The Effect of Bone Marrow Transplantation on the Osteoblastic Differentiation of Human Bone Marrow Stromal Cells
2002
Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots
2009
Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients
2007
Increased Risk of Type 2 Diabetes in Subjects with Both Elevated Liver Enzymes and Ultrasonographically Diagnosed Nonalcoholic Fatty Liver Disease: A 4-year Longitudinal Study
2013
Vitamin D Deficiency Is Associated with Sarcopenia in Older Koreans, Regardless of Obesity: The Fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009
2011
Effects of Two Common Polymorphisms of Peroxisome Proliferator-Activated Receptor-γ Gene on Metabolic Syndrome
2005
The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans
2006
Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
2012
ORIGINAL ARTICLE: The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle‐aged Korean subjects
2010
The short-term changes of bone mineral metabolism following bone marrow transplantation
2000
The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle‐aged men
2005
Circulating osteoprotegerin and receptor activator of NF‐κB ligand system are associated with bone metabolism in middle‐aged males
2004
Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
2011
Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women
2004
Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction
2011
Restoration of adiponectin expression via the ERK pathway in TNFα-treated 3T3-L1 adipocytes
2014
Long‐term Therapeutic Efficacy of Lamivudine Compared With Interferon‐α in Children with Chronic Hepatitis B: The Younger the Better
2007
Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes
2011
The Effect of Simvastatin on the Proliferation and Differentiation of Human Bone Marrow Stromal Cells
2005
Changes in the Serum Growth Factors and Osteoprotegerin after Bone Marrow Transplantation: Impact on Bone and Mineral Metabolism
2004